← Leaderboards
Mads Daugaard
Fred Hutchinson Cancer Research Center
$838,161
Attributed
$838,161
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $194.8K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$838,161 · 1
By mechanism
P50$838,161 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Joshi James Alumkal$6,560,072
- Gavin Ha$4,673,787
- Kieren A. Marr$13,002,180
- Colm M Morrissey$3,479,548
- Peter Nelson$3,139,960
Others in their field
Other Emerging Leaders on “First-In-Human”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Kathleen Maletic Neuzil · Emory University$27,466,472
- Sonia Minikel Vallabh · Broad Institute, Inc.$15,007,691
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
Research focus
First-In-HumanAffinityAnalogEngineeringAttributable MortalityBaseBindingBiological MarkersAdvanced Malignant NeoplasmBlood SpecimenCancer DiagnosticsCastration Resistant Prostate CancerCell CompartmentationChondroitin SulfatesCohortCompanion DiagnosticsComplexDesignBlood CellsAntibody AvidityDna RepairDoseDrug KineticsGlycosaminoglycans
Grant awards (6)
Project 3: Oncofetal Glycosaminoglycans as Molecular Targets in Prostate Cancer$146,046
P50 · FY2022 · CA · contact PI
Project 3: Oncofetal Glycosaminoglycans as Molecular Targets in Prostate Cancer$82,023
P50 · FY2021 · CA · contact PI
Project 3: Oncofetal Glycosaminoglycans as Molecular Targets in Prostate Cancer$72,067
P50 · FY2021 · CA · contact PI
Project 3: Oncofetal Glycosaminoglycans as Molecular Targets in Prostate Cancer$194,796
P50 · FY2020 · CA · contact PI
Project 3: Oncofetal Glycosaminoglycans as Molecular Targets in Prostate Cancer$170,386
P50 · FY2019 · CA · contact PI
Project 3: Oncofetal Glycosaminoglycans as Molecular Targets in Prostate Cancer$172,843
P50 · FY2018 · CA · contact PI